You searched for "ocular"
Daybreak Medical: Basic Ultrasound Course in Ophthalmology
26 June 2024
Chair: Mr Tarek El-Khashab
Faculty: Mr Peter Good and Mr Atta Hatem,
Course Programme
- Know your machine
- How to examine your patient
- UBM Principles
- Axial lens measurement
- Vitreoretinal Disorder
- Orbit and Ocular Nerve
- Hands-on Training
09:00-17:00
Max 25 delegates per course
Daybreak Medical Ltd: Advanced Ultrasound Course in Ophthalmology
25 September 2024
Chair: Mr Tarek El-KhashabFaculty: Mr Peter Good, Mr Atta Hatem and Mr Heinrich Heimann 09:00-17:00 Course Programme- Know your Machine- How to Examine your Patient- UBM in Detail- Axial Lens Measurement- Ocular Tumours in Detail- Opaque Medium- Vitreoretinal Disorders in...
ARVO (The Association for Research in Vision and Ophthalmology) 2025
4 May 2025
-8 May 2025
i3: imagining innovation and intelligence in vision science This is an incredibly exciting time in ophthalmology and vision science research. Technological innovations have allowed us to probe the workings of the eye from the microscopic to the macroscopic level with...
Daybreak Medical: Ophthalmic Ultrasound Seminar 2 Day Course "From Theory to Practice"
30 April 2025
-1 May 2025
Course ProgrammeDay One:-Registration and Welcome-Introduction: applied Basics and Principles-B-Scan: How to Perform and Obtain the Best Images-Standardised A-Scan: Guest Speaker-Biometry: A-Scan, B-Scan and IOL Calculations-Opaque Media/Dense Cataracts-Vitreoretinal Disorders and Trauma-Hands on Training with Real Patients and Biometry Workshop Day Two:-Ultrasound...
Bandage contact lens cultures after corneal collagen cross-linking
1 August 2016
| Saruban Pasu
|
EYE - Cornea, EYE - General
|
Bacterial contamination, contact lens, corneal collagen cross-linking, keratoconus, photorefractive keratotomy
Corneal collagen cross-linking (CCL) is a treatment modality that has been shown to stop the progression of keratoconus. There have also been reports that CCL acts as an antimicrobiologic agent in treating resistant microbial keratitis. This study aimed to investigate...
Coeliac disease and anterior scleritis
The authors present an interesting case report of recurrent anterior scleritis. Circulating IgA and IgG auto-antibodies directed against tissue transglutaminase, endomisium and gliadin are frequently elevated in patients with coeliac disease. The classic symptoms remain chronic diarrhoea, malabsorption syndromes and...
Intravitreal triamcinolone for uveitic macular oedema
1 June 2016
| Saruban Pasu
|
EYE - Vitreo-Retinal
This paper from South Korea reports on a prospective, double blind, randomised clinical study designed to evaluate the additional benefit of intravitreal triamcinolone (TA) administration for noninfectious uveitic macular oedema as an adjunct therapy to systemic anti-inflammatory treatment. Patients were...
Combined anti-VEGF and PDT for wet AMD
1 February 2014
| Brian Ang
|
EYE - Vitreo-Retinal
The authors report on a retrospective case series of combined anti-VEGF and photodynamic therapy (PDT) in the treatment of wet age-related macular degeneration (AMD) refractory to anti-VEGF monotherapy alone. The criteria for treatment failure of anti-VEGF monotherapy were persistent subretinal...
Four year outcomes of macular degeneration treated with ranibizumab
1 February 2014
| Brian Ang
|
EYE - Vitreo-Retinal
The authors report on a retrospective study of neovascular age-related macular degeneration (AMD) patients treated with a variable ranibizumab dosing regimen over a period of four years (from January 2007 to December 2011). A total of 600 treatment naïve eyes...
Steroid treatment for pseudophakic cystoid macular oedema
1 October 2021
| Kurt Spiteri Cornish
|
EYE - Vitreo-Retinal
|
Cystoid macular edema, intravitreal steroids, triamcinolone
The authors present a retrospective comparison of 45 eyes of 41 patients treated with 2mg intravitreal triamcinolone (IVT group) and 50 eyes of 42 patients treated with 40mg sub-Tenons triamcinolone (STT group) for pseudophakic cystoid macular oedema (CMO). The visual...
Intravitreal dexamethasone in diabetic macular oedema (DMO) - enhancing the response to anti-VEGF in non- or poor responders
3 February 2023
| Sofia Rokerya
|
EYE - Vitreo-Retinal
|
Aflibercept, Anti-VEGF, Dexamethasone implant, Diabetic macular oedema, Persistent, Ranibizumab, Resistant
This study aimed to describe the outcomes of a switch back from DEXi (dexamethasone implant) to anti-VEGF therapy in eyes that were treated temporarily with DEXi after an initial poor response to anti VEGF. Twenty-three eyes of 17 patients were...
Toxoplasmosis and the associated retinochoroiditis: important facts and when to treat
1 April 2017
| Annie SeeWah Tung
|
EYE - Vitreo-Retinal
Annie SeeWah Tung provides an overview of toxoplasmosis retinochoroiditis, including guidance on which cases should be treated and the treatment options. Toxoplasmosis retinochoroiditis is an infectious condition that is characterised by retinochoroidal lesions commonly in the posterior pole and is...
